Epsilon Historical Cash Flow
| EPN Stock | 0.02 0.00 0.00% |
Analysis of Epsilon Healthcare cash flow over time is an excellent tool to project Epsilon Healthcare future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 790.5 K or Total Cash From Financing Activities of 1.4 M as it is a great indicator of Epsilon Healthcare ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Epsilon Healthcare latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Epsilon Healthcare is a good buy for the upcoming year.
Epsilon |
About Epsilon Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Epsilon balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Epsilon's non-liquid assets can be easily converted into cash.
Epsilon Healthcare Cash Flow Chart
Add Fundamental
Net Borrowings
The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Epsilon Healthcare's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Epsilon Healthcare current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Epsilon Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Epsilon Healthcare's Sale Purchase Of Stock is comparatively stable compared to the past year. Other Cashflows From Financing Activities is likely to gain to about 1.9 M in 2024, whereas Total Cash From Operating Activities is likely to drop (2.4 M) in 2024.
| 2020 | 2021 | 2023 | 2024 (projected) | Stock Based Compensation | 7.3K | 1.1M | 984.7K | 600.5K | Issuance Of Capital Stock | 10.6M | 2.4M | 2.8M | 2.7M |
Epsilon Healthcare cash flow statement Correlations
Click cells to compare fundamentals
Epsilon Healthcare Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Epsilon Healthcare cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | 4.5M | 10.8M | 2.5M | 2.9M | 2.6M | 4.6M | |
| Change In Cash | (2.8M) | 3.4M | (4.6M) | (1.5M) | (1.3M) | (1.3M) | |
| Total Cashflows From Investing Activities | (714.7K) | (1.7M) | (737.6K) | (529.4K) | (608.8K) | (639.3K) | |
| Other Cashflows From Financing Activities | (714.7K) | (559.0K) | (929.7K) | 1.6M | 1.8M | 1.9M | |
| Capital Expenditures | 714.7K | 1.2M | 747.7K | 529.4K | 476.5K | 790.5K | |
| Total Cash From Operating Activities | (7.9M) | (8.7M) | (5.4M) | (2.6M) | (2.3M) | (2.4M) | |
| Total Cash From Financing Activities | 5.8M | 14.6M | 1.5M | 1.6M | 1.4M | 1.4M | |
| End Period Cash Flow | 3.6M | 7.0M | 2.3M | 862.0K | 775.8K | 737.0K | |
| Change To Inventory | (6.3K) | (386.1K) | (456.6K) | 2.4M | 2.8M | 2.9M | |
| Investments | (714.7K) | (1.7M) | (737.6K) | (529.4K) | (608.8K) | (639.3K) | |
| Free Cash Flow | (8.6M) | (9.9M) | (6.2M) | (3.1M) | (2.8M) | (2.9M) | |
| Change In Working Capital | (147.2K) | (119.9K) | (988.4K) | 3.2M | 3.7M | 3.9M | |
| Begin Period Cash Flow | 6.3M | 3.6M | 7.0M | 2.3M | 2.1M | 4.1M | |
| Depreciation | 222.1K | 1.6M | 1.1M | 1.9M | 2.1M | 2.2M | |
| Change To Account Receivables | (668.9K) | (1.1M) | (843.7K) | (795.2K) | (715.6K) | (751.4K) | |
| Net Income | (11.7M) | (10.5M) | (9.2M) | (13.3M) | (12.0M) | (12.6M) | |
| Change To Netincome | 3.9M | 395.2K | 3.7M | 8.2M | 9.5M | 10.0M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Epsilon Stock Analysis
When running Epsilon Healthcare's price analysis, check to measure Epsilon Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Epsilon Healthcare is operating at the current time. Most of Epsilon Healthcare's value examination focuses on studying past and present price action to predict the probability of Epsilon Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Epsilon Healthcare's price. Additionally, you may evaluate how the addition of Epsilon Healthcare to your portfolios can decrease your overall portfolio volatility.